Physician profile
Manik Goel
NPI 1306133103
$3,283.67
in general payments reported to CMS, 2019-2025
18 companies · $715 in 2025
The $715 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $113 · 2021: $96.19 · 2022: $272 · 2023: $1,354 · 2024: $443 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993 · Consulting Fee: $500 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,993.07 |
| Consulting Fee | $500.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,627.02 | 2022-2025 | |
| Microsurgical Technology, INC. | $500.00 | 2023 | |
| Alcon Vision LLC | $246.18 | 2019-2025 | Hydrus Microstent, Clareon, Rocklatan |
| Bausch & Lomb Americas INC. | $176.57 | 2023-2024 | Miebo, Vyzulta |
| Aerie Pharmaceuticals, INC. | $119.58 | 2019 | |
| Allergan, INC. | $113.44 | 2020 | |
| Ivantis, INC | $96.19 | 2021 | |
| Glaukos Corporation | $76.04 | 2025 | Idosetr |
| Dompe US, INC. | $72.92 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.79 | 2019 | |
| Mallinckrodt Hospital Products INC. | $43.61 | 2022 | |
| Rxsight INC | $42.65 | 2023 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Harrow Eye, LLC | $23.41 | 2025 | Vevye |
| Thea Pharma INC. | $22.54 | 2023 | Iyuzeh |
| Ocular Therapeutix, INC. | $17.78 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.91 | 2024 | Tepezza |
| Rayner Intraocular Lenses Limited | $14.37 | 2024 | Omidria, Rayone Spheric, Rayone Emv |
| Sun Pharmaceutical Industries INC. | $13.67 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manik Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.